6 news items
Evaxion Receives Nasdaq Notification
EVAX
10 May 24
, political, legal, compliance, social and business factors, including inflation, and the effects on our business from the worldwide ongoing COVID-19 pandemic
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
EVAX
17 Apr 24
factors, including inflation, and the effects on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
EVAX
2 Apr 24
, and the effects on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia
Evaxion Announces Business Update and Full Year 2023 Financial Results
EVAX
27 Mar 24
, and the effects on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
EVAX
19 Mar 24
the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East; and other uncertainties
vtdalj1
EVAX
29 Feb 24
inflation, and the effects on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia
- Prev
- 1
- Next